...
首页> 外文期刊>Orthopaedic Journal of Sports Medicine >Meniscal Repair with Concurrent Anterior Cruciate Ligament Reconstruction: Is ACL Graft Choice Predictive of Meniscal Repair Success?
【24h】

Meniscal Repair with Concurrent Anterior Cruciate Ligament Reconstruction: Is ACL Graft Choice Predictive of Meniscal Repair Success?

机译:并发前交叉韧带重建半月板修复:ACL移植选择是否可预测半月板修复成功?

获取原文
           

摘要

Objectives: The success rate of meniscal repair is known to increase with concurrent anterior cruciate ligament (ACL) reconstruction. However, the influence of ACL graft choice has not been described. The current study examines the effect of ACL graft choice on the outcome of meniscal repair performed in conjunction with ACL reconstruction (ACLR). Methods: Patients who underwent meniscal repair with concurrent primary ACLR were identified from a longitudinal, prospective cohort. Patient demographics and subjective outcome measures including the International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome Score (KOOS), and Marx activity rating scale were collected preoperatively. Arthroscopic assessment of meniscal tear characteristics and associated repair technique were recorded intraoperatively. Patients with subsequent repair failure, defined as any subsequent surgical procedure addressing the meniscus repaired at index surgery, were identified and operative notes were obtained in order to accurately classify pathology and treatment. A logistic regression model was built to assess the association of patient specific factors, ACL graft, baseline Marx activity level and meniscal tear laterality with the occurrence of repair failure at 6-year follow-up. Results: A total of 646 patients underwent ACLR with concurrent meniscal repair. Bone-patellar tendon-bone (BTB) and soft tissue (ST) autograft were used in 55.7% and 33.9% of cases, respectively, while allografts were utilized in the remaining cases. Table 1 summarizes the univariate analysis of each baseline variable. A total of 101 patients (15.6%) required subsequent surgery on the meniscus repaired at index surgery, including 89 meniscectomies (87 partial, 2 subtotal), 11 revision meniscal repairs, and 1 meniscus allograft transplantation. No statistically significant difference in meniscal repair failure rate was observed based on patient age, sex, BMI or smoking status. The odds of meniscal repair failure within 6 years of surgery for patients with only a lateral meniscal repair are 68% less than those with only a medial meniscal repair (CI: 41%, 83%; p&0.001). There is a statistically significant relationship between baseline Marx activity and the risk of subsequent meniscal repair, though it is nonlinear—patients with low or high baseline activity are at the highest risk of meniscal repair failure (CI: 1.05,1.31; p=0.004, Figure 1). The estimated odds of meniscal repair failure for BTB allograft, ST allograft, and ST autograft were 2.78 (CI: 0.84,9.19; p=0.09), 2.29 (CI: 0.97,5.45; p=0.06), and 1.42 (CI:0.87,2.32; p=0.16) times that of BTB autograft, respectively, although none proved statistically significant. Meniscal repair failure is associated with significantly lower 6-year scores for all KOOS components and the IKDC (p&0.001). However, there was no significant difference in MARX activity at 6-years (p=0.27). Conclusion: In the setting of primary ACLR, the risk of meniscal repair failure is increased with medial versus lateral meniscal repair. Patients with low or high baseline activity levels are also at an increased risk. ACL graft choice seems to have an effect on meniscal repair failure that approaches but does not reach statistical significance. A larger sample size may be required to accept the null hypothesis. Table 1. Univariate summary of each baseline characteristic Variable Level Summary Age (years) 20.00 (16.00, 28.00) Sex Female 281 (43.50%) Male 365 (56.50%) BMI 24.40 (22.0, 27.40) NA 11 (1.70%) Smoking Status Current 64 (9.91%) Never 524 (81.11%) Quit 46 (7.12%) NA 12 (1.86%) Baseline Marx Activity 14.00 (9.00, 16.00) NA 4 (0.62%) ACL graft type Allograft (BTB) 22 (3.41%) Autograft (BTB) 360 (55.73%) Allograft (Soft tissue) 45 (6.97%) Autograft (Soft tissue) 219 (33.90%) Meniscal repair location Both 39 (6.04%) Lateral 187 (28.95%) Medial 420 (65.02%) Vaues reported as median (IQR) for numeric values and counts (%) for categorical variables BMI, Body mass index; BTB, Bone-patellar tendon-bone; NA, Not available Figure 1. Profile plot of the relationship between baseline MARX activity and the risk of subsequent meniscal repair
机译:目的:已知半月板修复的成功率随着同时进行的前交叉韧带(ACL)重建而增加。但是,尚未描述ACL移植物选择的影响。本研究检查了ACL移植物选择对结合ACL重建(ACLR)进行的半月板修复的效果。方法:从纵向,前瞻性队列中鉴定出同时进行原发性ACLR进行半月板修复的患者。术前收集患者的人口统计学和主观结果指标,包括国际膝关节文献委员会(IKDC),膝关节损伤和骨关节炎结果评分(KOOS)以及马克思活动量表。术中记录关节镜下评估的半月板撕裂特征及相关修复技术。确定了随后修复失败的患者,定义为针对在索引手术中修复的半月板进行的任何后续外科手术,并获得手术记录,以准确分类病理学和治疗。建立了Logistic回归模型,以评估患者特定因素,ACL移植物,基线Marx活动水平和半月板撕裂偏侧性与6年随访中修复失败发生的相关性。结果:总共646例患者接受了ACLR并发半月板修复。自体骨-骨腱(BTB)和软组织(ST)分别用于55.7%和33.9%的病例,而在其余病例中使用同种异体移植。表1总结了每个基线变量的单变量分析。共有101例患者(15.6%)需要在指数手术中修复半月板后进行后续手术,包括89例半月板切除术(87例局部,2例小计),11例修订半月板修复和1例半月板同种异体移植。根据患者年龄,性别,BMI或吸烟状况,在半月板修复失败率方面没有统计学上的显着差异。仅进行外侧半月板修复的患者在手术后6年内发生半月板修​​复失败的几率比仅进行半月板内侧修复的患者低68%(CI:41%,83%; p <0.001)。基线马克思活性和随后的半月板修复风险之间存在统计学上的显着关系,尽管这是非线性的—基线活动低或高的患者半月板​​修复失败的风险最高(CI:1.05,1.31; p = 0.004,图1)。 BTB同种异体移植,ST同种异体移植和ST自体同种异体半月板修复失败的估计几率分别为2.78(CI:0.84,9.19; p = 0.09),2.29(CI:0.97,5.45; p = 0.06)和1.42(CI:0.87) ,2.32; p = 0.16)分别是BTB自体移植的两倍,尽管无统计学意义。半月板修复失败与所有KOOS组件和IKDC的6年评分显着降低相关(p <0.001)。但是,在6年的时间里,MARX活性没有显着差异(p = 0.27)。结论:在原发性ACLR的情况下,内侧半月板修复与外侧半月板修复相比,半月板修复失败的风险增加。基线活动水平低或高的患者的风险也增加。 ACL移植物的选择似乎对半月板修复失败有影响,但没有达到统计学意义。接受零假设可能需要更大的样本量。表1.每个基线特征的单变量汇总变量水平汇总年龄(年)20.00(16.00,28.00)性别女性281(43.50%)男性365(56.50%)BMI 24.40(22.0,27.40)NA 11(1.70%)吸烟状况当前64(9.91%)从不524(81.11%)退出46(7.12%)不适用12(1.86%)基准马克思活动14.00(9.00,16.00)不适用4(0.62%)ACL移植类型同种异体移植(BTB)22(3.41% )自体移植(BTB)360(55.73%)同种异体移植(软​​组织)45(6.97%)自体移植(软​​组织)219(33.90%)半月板修复位置两者39(6.04%)外侧187(28.95%)内侧420(65.02%) )报告为数字的中位数(IQR)值和分类变量BMI,体重指数的计数(%); BTB,B骨腱-骨;不适用,不可用图1.基线MARX活动与随后的半月板修复风险之间关系的概图

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号